The innovative catheter that meets all the needs of vein ablation therapy
Doctors and patients have been asking for a pain-free, effective,
non-thermal, and non-tumescent vein ablation device. We answered.
Understanding CVI
More Importantly, what can be done to fix it
Chronic venous insufficiency (CVI) is a condition that occurs when the venous wall and/or valves in the leg veins are not working effectively, making it difficult for blood to return to the heart from the legs due to gravity. CVI causes blood to “pool” or collect in these veins, and this pooling is called stasis. It’s a condition that leaves the patient in considerable discomfort, with less than desirable treatment options…. Until now.
“Advances in medicine involve improved patient safety, comfort, and outcomes. The next big advance in the treatment of chronic venous insufficiency (CVI) is here now and it is the BASIS catheter system.”
How BASIS Works
Our revolutionary patent-pending process
BASIS is an endovenous, chemical ablation procedure for the treatment of superficial venous insufficiency, which uses a dual-balloon system inflated to isolate a specific segment of a diseased blood vessel, remove the blood therein, instill an FDA approved ablative chemical (sclerosant) for a specified period of time, then remove the sclerosant. Finally, the balloons are deflated and the catheter repositioned for the next treatment segment.
No More Needles
No more painful needle sticks to deliver tumescent anesthesia.
Shorter Recovery
Current treatment options can leave you with 2 weeks of recovery time
Patented Solution
BASIS has filed for patent protection on both the procedure and the BASIS catheter.
Better Results
Look better and feel better for longer. BASIS gives you the confidence you miss.
Learn more about BASIS
Ready to Get Started?
BASIS is a best in class solution to a problem that affects 30-35 million Americans. Ready to get in on the future of CVI treatment? For more information or to speak with our team, please share your information and we will be in touch.